The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resection
Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
The current study is a prospective, randomized, open, multi-center investigation. The aim of
current study is to investigate whether the Recurrence-free Survival Rate (RFS）of the
hepatitis B related -hepatocellular carcinoma subjects who have been treated by resection can
be improved by peginterferon alfa-2a